CJC-1295: With and Without DAC - Research Comparison

CJC-1295: With and Without DAC - Research Comparison

CJC-1295 is a synthetic peptide analog of Growth Hormone Releasing Hormone (GHRH), also known as Growth Hormone Releasing Factor (GRF). Its primary function is to stimulate the release of growth hormone (GH) from the pituitary gland. CJC-1295 exists in two primary forms: CJC-1295 without Drug Affinity Complex (DAC), also known as Modified GRF 1-29 or Mod GRF 1-29, and CJC-1295 with DAC. This difference in structure significantly impacts their pharmacokinetic profiles and, consequently, their research applications.

Understanding the Structures

The fundamental structure of CJC-1295 is based on the first 29 amino acids of the naturally occurring GHRH. Mod GRF 1-29 retains this structure, providing a short-acting GHRH analog. CJC-1295 with DAC, on the other hand, has a lysine molecule attached to the N-terminus, which is then bound to a complex called DAC. This DAC moiety covalently binds to serum albumin in vivo, effectively extending the peptide’s half-life.

Mod GRF 1-29 (CJC-1295 without DAC): Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂. Molecular Weight: 3368.9 g/mol. Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

CJC-1295 with DAC: The exact molecular formula and weight are variable depending on the DAC moiety attached. The core peptide sequence is the same as GHRH(1-29), but with a lysine residue added to the N-terminus and covalently linked to the DAC. The DAC is typically a maleimide-based derivative that reacts with free thiol groups on albumin.

Mechanism of Action

Both forms of CJC-1295 act by binding to the GHRH receptor on pituitary somatotrophs. This binding stimulates the synthesis and pulsatile release of GH. The key difference lies in the duration of action. Mod GRF 1-29 produces a short, pronounced pulse of GH release, mimicking the natural pulsatile secretion of GH. CJC-1295 with DAC, due to its extended half-life, provides a more sustained, albeit less pronounced, increase in GH levels.

It is crucial to understand that GH release is also regulated by somatostatin, an inhibitory hormone. Therefore, the effectiveness of CJC-1295, regardless of the form, depends on the interplay between GHRH and somatostatin levels. This interplay often results in more pronounced GH pulses at night when somatostatin levels are naturally lower.

Research Applications

The choice between Mod GRF 1-29 and CJC-1295 with DAC depends on the specific research question being addressed. Here's a comparison:

For example, researchers investigating the acute effects of GH on glucose metabolism might prefer Mod GRF 1-29, allowing them to precisely control the timing and magnitude of GH pulses. Conversely, researchers studying the long-term effects of elevated GH on muscle growth or bone density might opt for CJC-1295 with DAC due to its longer half-life.

Quality Markers and Assessment

Ensuring the quality of CJC-1295 peptides is paramount for reliable research outcomes. Here are key quality markers to look for and methods for assessment:

1. Peptide Purity

Purity refers to the percentage of the desired peptide in the final product, excluding any impurities such as truncated sequences, diastereomers, or residual solvents. High purity is essential for accurate and reproducible results.

• Assessment Method: High-Performance Liquid Chromatography (HPLC) is the gold standard for determining peptide purity. Specifically, Reversed-Phase HPLC (RP-HPLC) is most commonly used.
• Acceptable Range: A purity level of ? 98% is generally considered acceptable for research purposes. Anything below 95% should raise concerns. For sensitive applications, >99% purity may be required.
• Practical Tip: Always request an HPLC chromatogram from the supplier. Examine the chromatogram for the presence of any significant impurity peaks. The area under the curve (AUC) of the main peak represents the percentage purity.

2. Peptide Identity

Identity confirmation ensures that the product is indeed the desired peptide sequence. This is critical to avoid using an incorrect compound.

• Assessment Method: Mass Spectrometry (MS) is used to determine the molecular weight of the peptide. The measured molecular weight should match the theoretical molecular weight of the peptide. Tandem mass spectrometry (MS/MS) can provide sequence confirmation.
• Acceptable Range: The measured molecular weight should be within ± 0.1% of the theoretical molecular weight.
• Practical Tip: Request MS data from the supplier. Confirm that the reported molecular weight matches the expected value. For critical applications, request MS/MS data to verify the amino acid sequence.

3. Peptide Content

Peptide content refers to the actual amount of peptide present in the vial, taking into account factors like residual water and counterions (e.g., acetate). This is crucial for accurate dosing.

• Assessment Method: Quantitative amino acid analysis (AAA) or UV spectrophotometry can be used to determine the peptide content. AAA involves hydrolyzing the peptide into its constituent amino acids and then quantifying each amino acid. UV spectrophotometry relies on the peptide's absorbance at a specific wavelength.
• Acceptable Range: The peptide content should be within ± 10% of the stated amount on the vial.
• Practical Tip: Ask the supplier for a Certificate of Analysis (CoA) that includes peptide content data. If the content is significantly lower than expected, adjust the dosage accordingly.

4. Water Content

Excessive water content can affect peptide stability and lead to inaccurate dosing. Lyophilized peptides typically contain some residual water.

• Assessment Method: Karl Fischer titration is the standard method for determining water content.
• Acceptable Range: Water content should ideally be ? 5%. Higher water content can indicate improper lyophilization or storage.
• Practical Tip: Inquire about the water content from the supplier. Store the peptide under desiccated conditions to minimize water absorption.

5. Counterion Content

Peptides are often synthesized as salts (e.g., acetate salts) to improve solubility. The counterion content needs to be considered for accurate dosing.

• Assessment Method: Ion chromatography (IC) can be used to determine the counterion content.
• Acceptable Range: The counterion content should be reported on the CoA.
• Practical Tip: Account for the counterion content when calculating the required peptide mass for a specific concentration.

6. Endotoxin Levels

Endotoxins, such as lipopolysaccharides (LPS), are bacterial toxins that can contaminate peptides and trigger immune responses. This is especially important for in vivo studies.

• Assessment Method: The Limulus Amebocyte Lysate (LAL) assay is used to detect and quantify endotoxins.
• Acceptable Range: Endotoxin levels should be ? 10 EU/mg (Endotoxin Units per milligram) for in vitro studies and ? 5 EU/mg for in vivo studies. For highly sensitive in vivo experiments, levels should ideally be < 1 EU/mg.
• Practical Tip: Request an endotoxin test report from the supplier, especially if the peptide is intended for in vivo use. Use sterile, pyrogen-free water or buffer for reconstitution.

Common Impurities

Several types of impurities can be present in synthetic peptides. Being aware of these impurities can help researchers assess the quality of their peptide preparations.

• Truncated Sequences: These are peptides that are missing one or more amino acids from the intended sequence. They arise from incomplete coupling during peptide synthesis.
• Diastereomers: These are isomers that differ in the configuration of one or more chiral centers. They can occur due to racemization during synthesis.
• Deletion Sequences: These are peptides where one or more amino acids are missing from within the sequence.
• Modified Amino Acids: These can include oxidized amino acids (e.g., methionine sulfoxide), deamidated asparagine or glutamine, or peptides with protecting groups still attached.
• Solvents and Reagents: Residual solvents (e.g., DMF, acetonitrile) and reagents used during synthesis can contaminate the final product.

Storage Requirements

Proper storage is crucial for maintaining peptide stability and preventing degradation. Here are general guidelines:

• Temperature: Store lyophilized peptides at -20°C or -80°C for long-term storage. Avoid repeated freeze-thaw cycles.
• Desiccation: Store peptides under desiccated conditions to minimize water absorption. Use a desiccant in the storage container.
• Light Exposure: Protect peptides from light, especially UV light, as it can cause degradation. Store in amber vials or wrap the vials in foil.
• Reconstitution: Reconstitute peptides with sterile, pyrogen-free water or buffer immediately before use. Avoid storing reconstituted peptides for extended periods, as they are more susceptible to degradation in solution. For short-term storage of reconstituted peptides (e.g., a few days), store at 4°C. For longer storage, aliquot and freeze at -20°C or -80°C.
• Buffer Selection: When reconstituting peptides, choose a buffer that is compatible with the peptide sequence and the intended application. Avoid buffers that contain components that could react with the peptide.

Sourcing Considerations

Choosing a reputable peptide supplier is critical for obtaining high-quality peptides. Consider the following factors when selecting a supplier:

• Reputation and Experience: Look for suppliers with a proven track record and extensive experience in peptide synthesis.
• Quality Control: Ensure that the supplier has robust quality control procedures in place, including HPLC, MS, and other analytical methods.
• Certificate of Analysis (CoA): Always request a CoA for each peptide batch. The CoA should include detailed information about purity, identity, content, water content, and other relevant parameters.
• Customer Support: Choose a supplier that provides excellent customer support and is responsive to your inquiries.
• Pricing: While price is a factor, it should not be the sole determinant. Prioritize quality and reliability over the lowest price.

Key Takeaways

• CJC-1295 exists in two forms: Mod GRF 1-29 (without DAC) and CJC-1295 with DAC, which differ in their pharmacokinetic profiles.
• Mod GRF 1-29 provides short, pronounced GH pulses, while CJC-1295 with DAC offers sustained GH elevation.
• The choice between the two depends on the specific research question and the desired duration of action.
• Key quality markers for CJC-1295 peptides include purity, identity, content, water content, counterion content, and endotoxin levels.
• HPLC and MS are essential analytical techniques for assessing peptide quality.
• Proper storage is crucial for maintaining peptide stability.
• Choose a reputable supplier with robust quality control procedures.